# C_2006084EN.01000901.xml

| 7.4.2006 | EN | Official Journal of the European Union | C 84/9 |
| --- | --- | --- | --- |

7.4.2006

EN

Official Journal of the European Union

C 84/9

---

Prior notification of a concentration

(Case COMP/M.4146 — GE/Bayer/OSi Europe Business)

(2006/C 84/04)

(Text with EEA relevance)

| 1. | On 29 March 2006, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings General Electric Company (‘GE’, USA) and Bayer AG (‘Bayer’,Germany) acquire joint control within the meaning of Article 3(1)(b) of the EC Merger Regulation partly through the existing joint venture GE Bayer Silicones GmbH&Co KG (‘GEBS’), partly through a newly created joint venture, of the undertakings GE Speciality Materials (Suisse) Sarl, GE Silicones (Benelux) BVBA and GE Specialities Srl [all: ‘OSi Europe Business’] which are currently controlled by GE, by way of purchase of shares. |
| --- | --- |

1.

On 29 March 2006, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings General Electric Company (‘GE’, USA) and Bayer AG (‘Bayer’,Germany) acquire joint control within the meaning of Article 3(1)(b) of the EC Merger Regulation partly through the existing joint venture GE Bayer Silicones GmbH&Co KG (‘GEBS’), partly through a newly created joint venture, of the undertakings GE Speciality Materials (Suisse) Sarl, GE Silicones (Benelux) BVBA and GE Specialities Srl [all: ‘OSi Europe Business’] which are currently controlled by GE, by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | for GE: diversified technology and services; |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for GE: diversified technology and services;

| — | for Bayer: chemical and pharmaceutical products; |
| --- | --- |

—

for Bayer: chemical and pharmaceutical products;

| — | for OSi Europe Business: silicones. |
| --- | --- |

—

for OSi Europe Business: silicones.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4146 — GE/Bayer/OSi Europe Business, to the following address:





  European Commission |
| --- | --- |
| Competition DG |
| Merger Registry |
| J-70 |
| B-1049 Brussels |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4146 — GE/Bayer/OSi Europe Business, to the following address:

European Commission

Competition DG

Merger Registry

J-70

B-1049 Brussels

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---